Research shows life expectancy growth is slowing, with significant implications for health policies and individual planning ...

On World Cities Day, the World Health Organization (WHO) calls on national and city leaders to transform urban areas into ...

A vaccine that tackles the bacteria that cause up to 200 million childhood infections every year could be possible, experts ...

ProImmune Ltd, a global leader in life science reagents and services, today announced the launch of its new ProVE® SL Self-Loading MHC Class I Monomers.

Cancer immunotherapy, which uses drugs that stimulate the body's immune cells to attack tumors, is a promising approach to treating many types of cancer. However, it doesn't work well for some tumors, ...